Developing a gene expression signature for first-line treatment in metastatic CRC

Tempus RWD identifies a signature predictive of bevacizumab response in CRC

INDICATION

Colorectal

Related cases

Abstract digital pattern composed of varying shades of purple dots on a white background.

High WRN expression and immunotherapy outcomes in MSI-H/dMMR colorectal cancer

Abstract grid visualization with blue, orange, and faded squares, highlighting several black data points.

Transcriptomic profiles of treatment resistance in 1L mCRC

Abstract pixelated pattern in warm orange tones with diagonal lines and irregular shapes.

Analyzing specific KRAS variants and treatment outcomes in colorectal cancer